5-Chloro-3-iodo-1H-pyrrolo[3,2-b]pyridine

Catalog No.: 
ACCPQH967
CAS No.: 
1190310-88-3
Molecular Formula: 
C7H4ClIN2
Molecular Weight: 
278.48
5-Chloro-3-iodo-1H-pyrrolo[3,2-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$97.00In stockInquiry
5g98%$480.00In stockInquiry
25g98%$2376.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-3-iodo-1H-pyrrolo[3,2-b]pyridine
IUPAC Name5-chloro-3-iodo-1H-pyrrolo[3,2-b]pyridine
MDL No.MFCD12962967
Molecular FormulaC7H4ClIN2
Molecular Weight278.48
SMILESClC1=NC2=C(NC=C2I)C=C1
InChI KeyDTYKKMQQSSHZFS-UHFFFAOYSA-N
Synonym1190310-88-3 | A892746 | CS-0416168 | PB48004 | SY321254 | AMY2808 | 5-Chloro-3-iodo-1H-pyrrolo[3,2-b]pyridine | 5-CHLORO-3-IODO-4-AZAINDOLE | 5-Chloro-3-iodo-1H-pyrrolo[3,2-b]pyridine, AldrichCPR | BS-53003 | SCHEMBL16593315 | MFCD12962967 | 1H-Pyrrolo[3
CAS No.1190310-88-3
PubChem CID53412948

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACCPQH967 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDNEQ645 route compound structure diagram
    ACDNEQ64565156-94-7In Stock
  2. Then
  3. ACCPQH967 route product structure diagram
    ACCPQH9671190310-88-3In Stock
Inquiry

2. ACCPQH967 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPQH967 route product structure diagram
    ACCPQH9671190310-88-3In Stock
Inquiry

3. ACCPQH967 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPQH967 route product structure diagram
    ACCPQH9671190310-88-3In Stock
Inquiry

Comments (0)